Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Current Heart Failure Reports|July 23, 2005
Beta-blockers in heart failure: is more better?Lawrence Baruch, Prabhakara KunamneniPostgraduate Medicine|July 3, 2013
Laboratory monitoring of anticoagulant medications: focus on novel oral anticoagulantsLawrence BaruchJournal of Clinical Hypertension (Greenwich, Conn.)|May 11, 2004
Hypertension and the elderly: more than just blood pressure controlLawrence BaruchThe Annals of Pharmacotherapy|June 30, 2011
Potential inaccuracy of point-of-care INR in dabigatran-treated patientsLawrence Baruch, Olga ShermanThe Annals of Pharmacotherapy|November 22, 2013
Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patientsLawrence Baruch, Olga ShermanThe American Journal of Medicine|February 7, 2012
Interpretation of point-of-care INR results in patients treated with dabigatranJoanne van Ryn, Lawrence Baruch, Andreas ClemensCholesterol|May 28, 2013
Discordance of Non-HDL and Directly Measured LDL Cholesterol: Which Lipid Measure is Preferred When Calculated LDL Is Inaccurate?Lawrence Baruch, Valerie J Chiong, Sanjay Agarwal, et al.The American Journal of Cardiology|May 26, 2009
Effect on serum lipid levels of switching dose of ezetimibe from 10 to 5 mgLawrence Baruch, Sanjay Agarwal, Bhanu Gupta, et al.The American Journal of Managed Care|October 8, 2008
Ezetimibe 5 and 10 mg for lowering LDL-C: potential billion-dollar savings with improved tolerabilityLawrence Baruch, Bhanu Gupta, Sharon S Lieberman-Blum, et al.The American Journal of Cardiology|August 13, 2022
Benefits of Adding Glucagon-Like Peptide 1 Receptor Agonists to Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetic Patients With Atherosclerotic Disease and Heart FailurePersio David Lopez, Kirtipal Bhatia, Chandrashekar Bohra, et al.Pageof 2